RDAC · Rising Dragon Acquisition
Conviction · Low · more likely to lag the S&P 500 over the next three months
Wrong if: a daily close above $13.58
Note written ·
Price against the kill line
18.3% clear of its kill line on the 13 November 2026 close.
How to read this
This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close above $13.58, on record since 11 November 2026. The shares are up 91.0% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close above $13.58, which would show the shares trading well above their trust value on a new deal and leading the S&P 500. A signed merger agreement with a new target would point the same way.
Research onlyNot in the portfolio.
Catalyst
The business · as of
Rising Dragon Acquisition Corp. is a Cayman Islands blank-check company based in Taiyuan, China. It raised $57.5 million in its October 2024 IPO and holds the money in a trust account while it looks for a merger target. It reports no revenue.
What is changing, and what follows · as of
- What is changing now
- The company and HZJL Cayman Limited mutually ended their 27 January 2025 merger agreement effective 30 October 2026, with no termination fee; the company announced it on 3 November 2026 (8-K).
- What follows for the company
- The 10-Q filed 12 November 2026 shows cash of $0.0 million, equity of −$3.4 million and net income of $0.1 million for the quarter to 30 September 2026. Sponsor notes fund the monthly extensions.
- What follows for its customers, suppliers and competitors
- HZJL Cayman Limited, the former target, has no US-listed ticker. The company names no replacement target, so no customer, supplier or competitor can be tied to it.
What the price assumes · as of
At the 13 November 2026 close (filed inputs to 12 November 2026) the shares trade at a P/E of 59.2, with market value $38 million, enterprise value $38 million, P/B not meaningful and EV/sales not available. That rests on a new deal or a trust payout, not on earnings: net income was $0.6 million over the four quarters to 30 September 2026.
Key figures from the filings · Financials
Quarter to 30 September 2026, filed 12 November 2026; valuation at the 13 November 2026 close
- Net cash, cash less debt ($M)
- −0.1
- Price to earnings (×)
- 59.2
All filed numbers
What Rising Dragon Acquisition reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Pre-tax income ($M) | Not reported |
| Net income ($M) four quarters: 0.6 | 0.1 |
| Diluted shares, change on a year (%) | Not reported |
| Operating cash flow ($M) | −0.8 |
| Capital spending ($M) | Not reported |
| Free cash flow ($M) | Not available |
| Cash and short-term investments ($M) | 0.0 |
| Debt ($M) at 31 December 2025, filed 30 March 2026; notes | 0.1 |
| Net cash, cash less debt ($M) at 31 December 2025, filed 12 November 2026 | −0.1 |
| Deferred revenue ($M) | Not reported |
| Backlog, orders not yet delivered ($M) | Not reported |
| Receivables ($M) | Not reported |
| Inventory ($M) | Not reported |
| Shareholders' equity ($M) | −3.4 |
| Market value ($M) | 38.1 |
| Enterprise value, market value plus net debt ($M) | 38.2 |
| Enterprise value to sales (×) | Not available |
| Enterprise value to operating income (×) | Not available |
| Price to earnings (×) | 59.2 |
| Price to book value (×) | Not meaningful |
| Free-cash-flow yield (%) | Not available |
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 0.7% of shares outstanding sold short, 2.6 days of average trading to cover, −25.3% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $0 | $0 |
| 12 monthsfrom | $0 | $0 |
The thesis
Rising Dragon Acquisition Corp. is a blank-check company with no operating business, and the shares are more likely to lag the S&P 500 over three months than to lead it. Its only merger ended on 30 October 2026, no replacement target is named, and the shares closed at $11.10 on 13 November 2026, above the $10.90 per-share trust value reported at 30 June 2026. The extension deadline on 15 November 2026 and any new merger agreement settle the case.
The mutual termination of the agreement with HZJL Cayman Limited, announced 3 November 2026, carried no termination fee for either side, according to the company's 8-K. The company said it will keep looking for a target. Its current deadline of 15 November 2026 was set by promissory notes totalling $55,637.41, issued on 30 October 2026 to fund the trust.
The 10-Q filed 12 November 2026 shows cash and short-term investments of $0.0 million at 30 September 2026, equity of −$3.4 million, and net income of $0.1 million for the quarter. Revenue is not reported. The shares closed between $11.10 and $11.22 on each of the six sessions from 6 November to 13 November 2026, a narrow range after the jump on the termination news.
Bullish and bearish views on Rising Dragon Acquisition Corp.
The bull case on Rising Dragon Acquisition Corp. (RDAC), in brief: trust value anchors the shares. The bear case: little room above trust value.
Bull case
- Trust value anchors the shares. The 10-Q for the quarter to 30 June 2026 lists 1,685,982 public shares subject to possible redemption at $10.90 each. Monthly deposits of $0.033 a share and trust interest have added to that figure since.
- The sponsor keeps paying to extend. On 30 October 2026, after the merger had ended, the company issued $55,637.41 of promissory notes to fund the trust and move the deadline to 15 November 2026. Funding an extension after a collapsed deal is consistent with a sponsor still seeking a new target.
- Deadline room runs to late 2027. The May 2026 proxy (DEF 14A filed 8 May 2026) proposed up to 15 monthly extensions, to 15 October 2027. That leaves time to sign a new target if each deposit is made.
- Deal news has moved the shares sharply. The shares reached an intraday high of $23.99 on 29 April 2026, the day after the extension proxy was filed. TipRanks reported a 117.5% premarket jump on 3 November 2026, the day the termination was announced.
Bear case
- Little room above trust value. The $11.10 close on 13 November 2026 sits above the $10.90 redemption value of 30 June 2026. A liquidation pays out about the trust value, so the shares have little to gain without a new deal.
- The trust floor has The shares closed at $4.56 on 31 August 2026, the 52-week closing low, well below the $10.90 per-share trust value reported at 30 June 2026. The current price near the trust value is a recent development, and the 50-day average close is $6.40.
- No target is named. The 3 November 2026 termination release gives no reason for the break-up and names no replacement. A new target needs due diligence, a signed agreement and a proxy.
- The Nasdaq listing is at risk. Nasdaq notified the company on 19 August 2026 that the market value of its listed securities was below the $35 million minimum (Rule 5550(b)(2)). It must close at or above $35 million for 10 consecutive business days by 16 February 2027 or face a delisting notice (8-K, 20 August 2026).
- The balance sheet is empty outside the trust. The 10-Q filed 12 November 2026 shows cash of $0.0 million and equity of −$3.4 million at 30 September 2026. Operating cash flow was −$0.8 million over the four quarters to that date, so sponsor loans cover running costs and extensions.
- The public float is small. Holders redeemed 2,515,673 shares on 29 May 2026 and 3 June 2026, leaving 1,685,982 public shares at 30 June 2026 (10-Q). A float this small can produce large moves on little volume in either direction.
Price setup
The last close was $11.10 on 13 November 2026. That is 53.7% below the 52-week intraday high of $23.99 set on 29 April 2026, and 91.0% above the $5.81 close of 17 August 2026, the three-month reference date. The 50-day average close is $6.40 and the 200-day average close is $6.39, both far below the price, because the shares only reached this range in November.
The level the case turns on is the $10.90 per-share trust value at 30 June 2026, which monthly deposits have raised since. A close below the current trust value per share would show the market pricing a liquidation or doubting the full payout.
Catalysts ahead
- 15 November 2026: Current business-combination deadline; another monthly extension deposit is required to continue. Funding the extension keeps the search for a new target alive. A failure to fund it points to liquidation at about the trust value.
- ~15 December 2026 (est.): Next monthly extension date, if the November extension is funded. A second extension after the termination would show the sponsor is still pursuing a deal.
- 16 February 2027: End of Nasdaq's 180-day period to regain the $35 million minimum market value of listed securities. Without a deal that lifts the company's market value, Nasdaq staff will issue a delisting notice.
What would change the view
A daily close above $13.58, which would show the shares trading well above their trust value on a new deal and leading the S&P 500. A signed merger agreement with a new target would point the same way.
What it trades with
RDAC trades on its own trust and deal news. It has no operating peers, and no current group of stocks moves with it. The shares have no meaningful link to the S&P 500. A broad market rally does not lift them, and a liquidation would leave them lagging the index, while a new merger agreement could send them sharply higher.
The evidence, claim by claim (7)
- Rising Dragon and HZJL Cayman Limited mutually terminated their 27 January 2025 merger agreement effective 30 October 2026, with no termination fee payable by either party. Rising Dragon Form 8-K and company release, 3 November 2026 · as of
- The company issued two unsecured promissory notes totalling $55,637.41 to fund the trust account and extend its business-combination deadline to 15 November 2026. Company announcement, 30 October 2026 · as of
- Net income was $0.1 million in the quarter to 30 September 2026 and $0.6 million over four quarters; cash and short-term investments were $0.0 million and equity was −$3.4 million (−$1.00 a share). Rising Dragon 10-Q filed 12 November 2026 · as of
- 1,685,982 ordinary shares were subject to possible redemption at $10.90 per share at 30 June 2026, after 2,515,673 shares were redeemed at about $10.83 on 29 May 2026 and 3 June 2026; the trust held $18.37 million. Rising Dragon 10-Q for the quarter to 30 June 2026, filed 7 August 2026 · as of
- Nasdaq notified the company that the market value of its listed securities was below the $35 million minimum under Rule 5550(b)(2); it has until 16 February 2027 to close at or above $35 million for 10 consecutive business days. Rising Dragon Form 8-K, Item 3.01, filed 20 August 2026 · as of
- The May 2026 proxy proposed up to 15 one-month extensions of the deadline, to 15 October 2027, with sponsor deposits into the trust for each month. DEF 14A filed 8 May 2026 · as of
- The shares rose 117.5% in premarket trading on 3 November 2026, the day the merger termination was announced. TipRanks, 3 November 2026 · as of
Sources
- Rising Dragon Acquisition Corp. - Form 8-K · sec.gov
- Rising Dragon Acquisition Corp. and HZJL Cayman Limited Announce Mutual Termination of Merger Agreement · finance.yahoo.com
- Why Is Penny Stock Rising Dragon Acquisition Corp. (RDAC) Up 117% Today? · tipranks.com
- Boardroom Alpha ·
- Rising Dragon stock skyrockets on SPAC extension proposal · stockti.com
Related · shared themes
RFAI
RF Acquisition Corp II
RF Acquisition Corp II, a blank-check shell awaiting its Nanyang Biologics merger, is more likely to lag the S&P 500 over three months: the…
XHG
XChange TEC.INC
XChange TEC.INC's shares trade on an AI-expansion plan with no disclosed First Cycle terms or US spending detail, so they are more likely…
U
Unity Software
Unity Software's advertising turnaround and reported takeover interest make the shares modestly more likely than not to beat the S&P 500…
CVS
CVS Health
CVS Health is modestly more likely to beat the S&P 500 over three months: Aetna's costs improved and 2026 guidance rose, and the February…